Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EK.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EK.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.233NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.233NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.233NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.320NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.320NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.320NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.635NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.635NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.635NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.19 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.19 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.19 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AM.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AM.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.15 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.15 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.15 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.113NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.113NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.113NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.5.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.5.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.88NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AP.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
AP.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AK.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used